Drugs / 6% Hydroxyethylstarch
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00300040 Comparator | May 2006 → Jun 2008 | peripheral vascular disease | Biopure Corporation | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 6% Hydroxyethylstarch | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00300040 ↗ |
| Route | Intravenous | “intravenous infusion” NCT00300040 ↗ |